The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.
about
New Insights in the Diagnosis and Treatment of Heart FailureChanges in practice patterns affecting in-hospital and post-discharge survival among ACS patientsDifferent treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?Chronic coronary artery disease: diagnosis and managementTCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortalityTCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population.Basal hyperinsulinemia beyond a threshold predicts major adverse cardiac events at 1 year after coronary angiogram in type 2 diabetes mellitus: a retrospective cohort study.Early increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.Genetic variants of diabetes risk and incident cardiovascular events in chronic coronary artery disease.A multi-region assessment of population rates of cardiac catheterization and yield of high-risk coronary artery disease.Economic evaluation of increasing population rates of cardiac catheterizationThe usefulness of xuefu zhuyu tang for patients with angina pectoris: a meta-analysis and systematic reviewInvestigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT studyFive-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery.Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial diseaseStratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects.Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trialsMedical angioplasty - hope and expectations: an optimistic overview.Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.Efficacy of Ligustrazine Injection as Adjunctive Therapy for Angina Pectoris: A Systematic Review and Meta-Analysis.Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center.Risk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Treatment of stable angina: medical and invasive therapy--implications for the elderly.Will drug-eluting stents replace coronary artery bypass surgery?Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic StrategiesFacts and principles learned at the 39th Annual Williamsburg Conference on Heart DiseaseMyocardial revascularization: surgery or stenting?Cardiac complications in type 2 diabetic patients with mild anginal symptoms and documented reversible myocardial perfusion defects: Results of the MERIDIAN trialKidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.Therapeutic strategies in patients with chronic stable coronary artery disease.Revascularization treatment of stable coronary artery disease.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiInitial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice.Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review.
P2860
Q26774884-F95B4287-3032-4AD9-9D3D-A294092101D8Q28201034-7650F620-5D7C-4945-AEE1-40BCD74B1161Q30319078-DF7C7495-4232-4119-9E7F-B99A9AFB6727Q30492121-9CA1ECE9-5ABB-4A73-8F0A-810134A70D61Q30895121-910FAE7A-D54B-4B17-9473-441517882F74Q33389614-BE06EFBE-D4D5-45B9-B269-5409C559733BQ33706452-B5932267-3B32-4B80-9D71-71742879DB6BQ33742308-E7E8F269-3641-4DF9-8EB0-1C3BBCCF94BDQ33809174-3BE645EB-A6BD-42F0-A1B4-80760DC581BCQ34083244-12ADBFCE-65AF-4D73-909C-FB39906ECBA3Q34083264-E8C6B36D-BA4D-4BC3-A215-BF3DE980FA89Q34181393-0DE64C66-E408-4B65-82FB-61F0220C5E3BQ34319896-775FB458-B29F-4637-B2E4-524A3D3B4940Q34331701-13EBA92A-916E-46D8-A322-501D45B7902CQ34362603-14087847-00AD-4484-9034-1028ED4C5B41Q34364029-7EFF4C7D-DC83-4160-8708-F51BAF5436C4Q34640197-A59B6344-6D81-4D2A-A01C-A58200095DF2Q35108606-19D226B8-BEA6-4A30-A39F-A7E6C9D5D4C3Q35434402-EAE1C8EF-7410-4EE5-9AD6-932BABA39BF2Q35610914-041F8FF5-733B-4567-91CC-E539CCFD0F65Q35698518-0C27298A-659D-43A5-90AF-3091E90D1693Q35854874-7EE6008F-9F62-423D-9D8A-8F81ADAC0080Q36061898-8FE59ADE-8A91-4A53-8EFE-C76782D86F5CQ36071090-A8D863B0-A0CA-4FC2-AF3E-0B2382A571E1Q36193239-0E7B5B61-956F-46C6-BE26-470310AA9528Q36360158-3859E71F-8144-4944-9D4B-19DE8C19A950Q36645771-300A892D-3446-4CA9-8263-389554DD23CDQ36664605-0ABCADA1-91B7-4D9F-8CA0-E571BB4F91C6Q36703114-195ABC82-5073-4ABB-99EE-2A73C2E267FAQ36836467-D15E0D48-C16F-4276-8720-ECFF84B631CDQ36917452-743C6BCB-EA5C-43FD-B745-65D3FE05064DQ37240763-63BCAEA9-2824-4D2B-8B70-AC7BF1345AECQ37599625-80014A6B-331B-4E44-81AA-26417BC9F723Q37682501-ED679D28-E232-4A66-85AE-BDC242BDE851Q37759029-CCEA4408-D9EB-44D5-8103-5172EBE46D50Q37827869-D7325F77-EA4C-4B2D-A0A3-E74819CDF1E3Q37953885-26AFF4E3-8BD5-49FB-8B30-61444F5126FDQ38007395-CEBE5A4E-3B1E-4D27-A7CD-11D91B071CAFQ38124877-80F8FC53-F717-4BFD-BE1E-2B654F795DAEQ38153783-8E73CEB4-7385-426E-BBEB-A942B546626C
P2860
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
The medicine, angioplasty, or ...... ery disease: one-year results.
@ast
The medicine, angioplasty, or ...... ery disease: one-year results.
@en
The medicine, angioplasty, or ...... ery disease: one-year results.
@nl
type
label
The medicine, angioplasty, or ...... ery disease: one-year results.
@ast
The medicine, angioplasty, or ...... ery disease: one-year results.
@en
The medicine, angioplasty, or ...... ery disease: one-year results.
@nl
prefLabel
The medicine, angioplasty, or ...... ery disease: one-year results.
@ast
The medicine, angioplasty, or ...... ery disease: one-year results.
@en
The medicine, angioplasty, or ...... ery disease: one-year results.
@nl
P2093
P1476
The medicine, angioplasty, or ...... tery disease: one-year results
@en
P2093
Bernard J Gersh
Eulógio M Martinez
Luiz A M César
Luiz B Puig
Paulo R Soares
Protásio L Luz
Sergio A Oliveira
Whady Hueb
P304
P356
10.1016/J.JACC.2003.08.065
P407
P577
2004-05-01T00:00:00Z